Bilton, Edward J. http://orcid.org/0000-0003-4293-1981
Mollan, Susan P. http://orcid.org/0000-0002-6314-4437
Article History
Received: 31 December 2022
Revised: 16 January 2023
Accepted: 30 January 2023
First Online: 14 February 2023
Competing interests
: Dr EJB has no competing interests to declare. Professor SPM reports consultancy fees (Invex Therapeutics); advisory board fees (Invex therapeutics; Gensight) and speaker fees (Heidelberg engineering; Chugai-Roche Ltd; Allergan; Santen; Chiesi; and Santhera).